Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-02, Stock:JNJ, The news for the past five days is as follows:
2018-07-26: NEWS1: Fight Inflation With Prudent Stock Market Investing.NEWS2: Fight Inflation With Prudent Stock Market Investing.NEWS3: Celgene Raises Revenue Guidance after Solid Growth in Q2 2018.NEWS4: 5 Dow Jones Stocks That Are Ready to Rise Again.NEWS5: 5 Dow Jones Stocks That Are Ready to Rise Again.NEWS6: Bristol-Myers (BMY) Beats on Q2 Earnings, Raises Outlook.NEWS7: Bristol-Myers (BMY) Beats on Q2 Earnings, Raises Outlook.NEWS8: Fight Inflation With Prudent Stock Market Investing.NEWS9: Dow Movers: V, TRV.NEWS10: Dow Movers: V, TRV.NEWS11: 3 Stocks That Could Double Your Money.NEWS12: 3 Stocks That Could Double Your Money.NEWS13: 5 Dow Jones Stocks That Are Ready to Rise Again.NEWS14: 3 Stocks That Could Double Your Money.
2018-07-27: NEWS1: All New Rules for This Market: Cramer's 'Mad Money' Recap (Friday 7/27/18).NEWS2: NYSE trader: Consumers are slowly retrenching because of trade uncertainty.NEWS3: Noteworthy Friday Option Activity: JNJ, STZ, REGN.NEWS4: Noteworthy Friday Option Activity: JNJ, STZ, REGN.NEWS5: AbbVie's (ABBV) Q2 Earnings Beat Estimates, 2018 View Up.NEWS6: AbbVie's (ABBV) Q2 Earnings Beat Estimates, 2018 View Up.NEWS7: Collaborations Help Alkermes Flip to Profitability.NEWS8: Collaborations Help Alkermes Flip to Profitability.NEWS9: Pfizer’s Q2 2018 Estimates: Expect Revenue Growth.NEWS10: Collaborations Help Alkermes Flip to Profitability.NEWS11: Pharma Favorites: 7 Healthy Picks in the Drug Sector.
2018-07-30: NEWS1: [$$] Johnson & Johnson Adds Zarbee’s Naturals to Bolster Consumer Brands.NEWS2: Celgene’s Revlimid and Pomalyst See Solid Growth.NEWS3: European Medicines Agency's CHMP Says Yes To 7 Drugs, No To 1.NEWS4: European Medicines Agency's CHMP Says Yes To 7 Drugs, No To 1.
2018-07-31: NEWS1: U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict.NEWS2: U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict.NEWS3: A Look at Dentsply Sirona’s Expected Bottom Line in Q2 2018.NEWS4: Why Editas Medicine Stock Fell in July.NEWS5: Pfizer Beat Wall Street Analyst Estimates for Q2 2018 Earnings.NEWS6: Pfizer CEO expects Trump to eliminate drug rebates.NEWS7: What to Expect for DaVita’s Q2 2018 Earnings.NEWS8: Pfizer (PFE) Beats on Q2 Earnings & Sales, Ups Profit View.NEWS9: Pfizer (PFE) Beats on Q2 Earnings & Sales, Ups Profit View.
2018-08-01: NEWS1: Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down.NEWS2: Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down.NEWS3: Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down.NEWS4: Why The 'Heat Wave' For U.S. Pharma Could Continue This Month.NEWS5: NYSE trader: American wealth and stock earnings are at record highs, so I can only be bullish.NEWS6: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for August 02, 2018.NEWS7: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for August 02, 2018.NEWS8: U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict.

Answer: Decrease